• Ep 42. Combination therapy or autologous hematopoietic stem cell transplantation for patients with progressive systemic sclerosis?

  • Jan 11 2024
  • Duración: 18 m
  • Podcast
Ep 42. Combination therapy or autologous hematopoietic stem cell transplantation for patients with progressive systemic sclerosis?  Por  arte de portada

Ep 42. Combination therapy or autologous hematopoietic stem cell transplantation for patients with progressive systemic sclerosis?

  • Resumen

  • Professor Doron Rimar joins Dr Cristiana Sieiro Santos to discuss their article, which retrospectively compares the outcomes of SSc patients who underwent AHSCT to patients who met the eligibility criteria for AHSCT but received upfront combination therapy with MMF and rituximab.

    Listen now to hear the findings and what this means for future clinical practice!

    You can read this article [https://doi.org/10.1093/rheumatology/kead457] in Rheumatology.

    Thanks for listening to Talking Rheumatology Research! Join the conversation on Twitter using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram.

    Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

    Más Menos

Lo que los oyentes dicen sobre Ep 42. Combination therapy or autologous hematopoietic stem cell transplantation for patients with progressive systemic sclerosis?

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.